FIELD: medicine; pharmaceutics.
SUBSTANCE: pharmaceutical dosage form in the form of a soft gelatinous capsule, which includes a soft gelatinous shell and filling, where: (a) soft gelatinous shell includes gelatine obtained by acid treatment of bones, and at least one plasticiser; and (b) the filling comprises an antioxidant, at least one solvent and thalazoparib or a pharmaceutically acceptable salt thereof.
EFFECT: what is disclosed is a dosage form of talazoparib in the form of a soft gelatine capsule.
15 cl, 6 dwg, 13 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL SOFT GELATIN CAPSULE DOSAGE FORM WITH MODIFIED GUAR GUM | 2014 |
|
RU2676480C2 |
| NEW COMPOSITION FOR SOFT GELATIN RETINOID-CONTAINING CAPSULES | 2004 |
|
RU2344810C2 |
| HC-1119 COMPOSITION, ITS PRODUCTION METHOD AND USE | 2019 |
|
RU2777008C2 |
| BENZIMIDAZOLYLPYRIDYL ESTER COMPOUNDS | 2007 |
|
RU2452469C2 |
| FORMULATIONS OF VITAMIN D 14-EPI-ANALOGUES | 2011 |
|
RU2575792C2 |
| NEW PHARMACEUTICAL COMPOSITION OF TAMSULOZIN AND DUTASTERIDE | 2019 |
|
RU2795928C2 |
| NEW FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D | 2011 |
|
RU2575819C2 |
| ORAL ANTITUMOUR DRUGS AND METHOD FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2639479C1 |
| DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION | 2011 |
|
RU2609833C2 |
| BIOLOGICALLY ACTIVE TOMATO COMPOSITION WITH REDUCED LICOPINE CONTENT | 2015 |
|
RU2748400C2 |
